Position in LH
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$115,360
-$7,639 QoQ
Shares Held
412
-10.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#821
of 1,040 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Spire Wealth Management holds $2,119,723 across 20 Diagnostics & Research names. LH ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,563 | $488,200 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
966 | $484,313 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
914 | $207,286 | |
| 4 | DGX |
Quest Diagnostics Inc
|
896 | $189,907 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
239 | $125,819 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
412 | $115,360 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
567 | $109,555 | |
| 8 | ICLR |
Icon PLC
|
613 | $106,484 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,360 | 412 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $122,999 | 461 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $116,659 | 465 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $140,085 | 488 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $128,629 | 490 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $125,912 | 541 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $146,535 | 639 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||